- Home
- BSET vs MNPR Comparison
BSET vs MNPR Comparison
Compare BSET & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSET
- MNPR
- Stock Information
- Founded
- BSET 1902
- MNPR 2014
- Country
- BSET United States
- MNPR United States
- Employees
- BSET N/A
- MNPR 12
- Industry
- BSET Home Furnishings
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- BSET Consumer Discretionary
- MNPR Health Care
- Exchange
- BSET Nasdaq
- MNPR Nasdaq
- Market Cap
- BSET 122.8M
- MNPR 292.9M
- IPO Year
- BSET 1987
- MNPR 2019
- Fundamental
- Price
- BSET $14.14
- MNPR $50.54
- Analyst Decision
- BSET
- MNPR Strong Buy
- Analyst Count
- BSET 0
- MNPR 4
- Target Price
- BSET N/A
- MNPR $43.00
- AVG Volume (30 Days)
- BSET 18.2K
- MNPR 67.7K
- Earning Date
- BSET 01-29-2025
- MNPR 03-27-2025
- Dividend Yield
- BSET 5.81%
- MNPR N/A
- EPS Growth
- BSET N/A
- MNPR N/A
- EPS
- BSET N/A
- MNPR N/A
- Revenue
- BSET $329,923,000.00
- MNPR N/A
- Revenue This Year
- BSET $3.42
- MNPR N/A
- Revenue Next Year
- BSET $5.50
- MNPR N/A
- P/E Ratio
- BSET N/A
- MNPR N/A
- Revenue Growth
- BSET N/A
- MNPR N/A
- 52 Week Low
- BSET $12.11
- MNPR $1.55
- 52 Week High
- BSET $15.96
- MNPR $49.98
- Technical
- Relative Strength Index (RSI)
- BSET 54.57
- MNPR 71.10
- Support Level
- BSET $13.77
- MNPR $34.41
- Resistance Level
- BSET $15.42
- MNPR $49.98
- Average True Range (ATR)
- BSET 0.59
- MNPR 6.18
- MACD
- BSET 0.04
- MNPR 1.29
- Stochastic Oscillator
- BSET 42.78
- MNPR 96.17
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.